2022-07-28| Special

BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka

by GeneOnline
Share To

The opening session of BIO-Asia Taiwan 2022 featured a presentation by Professor Shinya Yamanaka from Japan. Prof. Yamanaka, who was awarded the Nobel Prize in Physiology and Medicine in 2012 for his iPSC research, discussed the future vision of popularizing iPSC technology with the title “Top iPS Cell Technologies at Affordable Prices”.

CiRA’s Three Major Strategies for Accelerated Production of iPSC

The CiRA Foundation (Center for iPS Cell Research Application, Kyoto University), a leading regenerative medicine research institute in Japan, was established through the efforts of Prof. Yamanaka to shorten the gap between research and industry in iPSC technology. CiRA has three main strategies to facilitate the advancement of therapeutic applications of iPSC.

It's free! Log in now to read

NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
First Human Trial for Marburg Virus Vaccine Reports Success
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!